X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
humans (13) 13
migraine (13) 13
pharmacology & pharmacy (9) 9
female (8) 8
male (7) 7
middle aged (7) 7
adult (6) 6
aged (6) 6
animals (6) 6
migraine disorders - drug therapy (6) 6
neurosciences (6) 6
coronary vessels - drug effects (5) 5
young adult (5) 5
5-ht (4) 4
adolescent (4) 4
clinical neurology (4) 4
meningeal arteries - drug effects (4) 4
pharmacology (4) 4
receptors, calcitonin gene-related peptide - antagonists & inhibitors (4) 4
research (4) 4
trigeminal nucleus caudalis (4) 4
vasoconstrictor agents - pharmacology (4) 4
c-fos expression (3) 3
calcitonin gene-related peptide (3) 3
cgrp (3) 3
cgrp receptors (3) 3
coronary vessels - physiology (3) 3
drug therapy (3) 3
familial hemiplegic migraine (3) 3
headache (3) 3
human coronary artery (3) 3
in vitro techniques (3) 3
medicine & public health (3) 3
muscle contraction - drug effects (3) 3
neurology (3) 3
risk factors (3) 3
sumatriptan (3) 3
sumatriptan - pharmacology (3) 3
analysis (2) 2
annan klinisk medicin (2) 2
antimigraine drugs (2) 2
azepines - pharmacology (2) 2
bibn4096bs (2) 2
blood vessels - drug effects (2) 2
care and treatment (2) 2
cgrp receptor antagonist (2) 2
child (2) 2
clinical medicine (2) 2
closed cranial window (2) 2
cortical spreading depression (2) 2
cyclase-activating polypeptide (2) 2
cyclic amp - metabolism (2) 2
development and progression (2) 2
drug discovery - methods (2) 2
gene-related peptide (2) 2
glutamate (2) 2
imidazoles - pharmacology (2) 2
immunohistochemistry (2) 2
indoles - pharmacology (2) 2
internal medicine (2) 2
kirurgi (2) 2
klinisk medicin (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
medicine (2) 2
meningeal arteries - physiology (2) 2
methyl-d-aspartate (2) 2
microvascular spasm (2) 2
migraine disorders - physiopathology (2) 2
muscle contraction - physiology (2) 2
n-mc cells (2) 2
neuropeptides (2) 2
other clinical medicine (2) 2
pharmacokinetics (2) 2
pharmacology/toxicology (2) 2
pharmacotherapy (2) 2
pyridines - pharmacology (2) 2
randomized controlled-trial (2) 2
research article (2) 2
rna, messenger - genetics (2) 2
rna, messenger - metabolism (2) 2
serotonin receptor agonists - pharmacology (2) 2
surgery (2) 2
tegaserod (2) 2
telcagepant (2) 2
triptans (2) 2
tryptamines - pharmacology (2) 2
vasoconstriction (2) 2
vasodilation (2) 2
vasodilation - drug effects (2) 2
vasodilator agents - pharmacology (2) 2
15-hydroxy-11 alpha,9 alpha-prosta-5,13-dienoic acid - pharmacology (1) 1
5-ht 1b receptor (1) 1
5-ht 1b/1d receptor agonists (1) 1
5-ht1b receptor (1) 1
5-ht1b/1d receptor agonists (1) 1
5-ht1d receptors (1) 1
5-ht2b receptor antagonist (1) 1
5-ht4 receptors (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 4/2019, Volume 39, Issue 4, pp. 718 - 729
Familial hemiplegic migraine type 1 (FHM1) is a rare migraine subtype. Whereas transgenic knock-in mice with the human pathogenic FHM1 R192Q missense mutation... 
Calcitonin gene-related peptide | trigeminovascular | migraine | R192Q | vasodilation | VASCULAR-RESPONSES | TRIGEMINAL GANGLIA | CLOSED CRANIAL WINDOW | RELEASE | NEUROSCIENCES | SPREADING DEPRESSION | MOUSE MODELS | DEPENDENT CALCIUM-CHANNELS | ENDOCRINOLOGY & METABOLISM | CA2+ CHANNEL | HEMATOLOGY | FAMILIAL HEMIPLEGIC MIGRAINE | INTRAVITAL MICROSCOPY | Original
Journal Article
The Journal of Headache and Pain, ISSN 1129-2369, 12/2018, Volume 19, Issue 1, pp. 1 - 10
Migraine is considered a neurovascular disorder, but its pathophysiological mechanisms are not yet fully understood. Adenosine has been shown to increase in... 
Neurology | Pain Medicine | CGS21680 | Medicine & Public Health | Dural vasodilation | Rat, vasodepressor response | Internal Medicine | Adenosine receptor | Calcitonin gene-related peptide | Headache | Adenosine | Migraine | Rodents | Clinical trials | Blood vessels | Blood pressure | Vasodilation | Caffeine | Electrical stimuli | Index Medicus
Journal Article
Cephalalgia: an international journal of headache, ISSN 0333-1024, 10/2010, Volume 30, Issue 10, pp. 1233 - 1240
Journal Article
The Journal of Headache and Pain, ISSN 1129-2369, 12/2018, Volume 19, Issue 1, p. 1
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1186/s10194-018-0867-x Migraine... 
Migraine | Research | Drug therapy
Journal Article
CNS Drugs, ISSN 1172-7047, 3/2014, Volume 28, Issue 3, pp. 273 - 278
Journal Article
Cephalalgia, ISSN 0333-1024, 1/2011, Volume 31, Issue 2, pp. 181 - 189
Objective: We pharmacologically characterized pituitary adenylate cyclase–activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC1,... 
PAC1 | PACAP38 | VPAC1 | VIP | VPAC2 | CYCLASE-ACTIVATING POLYPEPTIDE | RAT | IMMUNOHISTOCHEMICAL LOCALIZATION | MIGRAINE | NEUROSCIENCES | PEPTIDE | CLINICAL NEUROLOGY | PAC | VPAC | MESSENGER-RNA | HEADACHE | CEREBRAL-ARTERIES | HEALTHY-VOLUNTEERS | EXPRESSION | Pituitary Adenylate Cyclase-Activating Polypeptide - antagonists & inhibitors | Receptors, Vasoactive Intestinal Polypeptide, Type I - antagonists & inhibitors | Gene Expression - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - agonists | Humans | Middle Aged | Male | Peptide Fragments - pharmacology | Receptors, Vasoactive Intestinal Peptide - genetics | RNA, Messenger - metabolism | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Meningeal Arteries - physiology | Vasoactive Intestinal Peptide - pharmacology | Receptors, Vasoactive Intestinal Polypeptide, Type I - agonists | Gene Expression - physiology | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Migraine Disorders - physiopathology | Adult | Female | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - agonists | Vasodilation - physiology | Coronary Vessels - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - antagonists & inhibitors | Vasodilator Agents - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | Coronary Vessels - physiology | Pituitary Adenylate Cyclase-Activating Polypeptide - adverse effects | Meningeal Arteries - drug effects | Migraine Disorders - drug therapy | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Aged | Receptors, Vasoactive Intestinal Peptide - antagonists & inhibitors | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Vasodilation - drug effects | Receptors, Vasoactive Intestinal Peptide - agonists | Vasoactive Intestinal Peptide - analogs & derivatives | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - antagonists & inhibitors | Index Medicus
Journal Article
The journal of headache and pain, 05/2018, Volume 19, Issue 1, p. 41
Migraine is considered a neurovascular disorder, but its pathophysiological mechanisms are not yet fully understood. Adenosine has been shown to increase in... 
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 2009, Volume 619, Issue 1, pp. 61 - 67
Journal Article
Journal Article